Lee G Wilke, MD, FACS


  • Director, UW Health Breast Center
  • Professor, Division of Surgical Oncology
  • Hendricks Chair in Breast Cancer Surgery Research

Clinic: (608) 266-6400

  • Administrative Assistant: (608) 262-2025

600 Highland Avenue
Box 7375 Clinical Science Center
Madison, WI 53792


  • MD, Duke University, Durham, NC, 1993
  • Residency in Surgery, University of Michigan, Ann Arbor, Michigan, 1993-2000
  • ACS Resident Research Fellow in Immunotherapy, University of Michigan, Ann Arbor, MI 1996-1998

Clinical Specialties

Dr. Wilke is certified by the American Board of Surgery and specializes in benign and malignant diseases of the breast; sentinel lymph-node mapping; neoadjuvant therapy for breast cancer; and oncoplastic breast surgery.

Research Interests

Dr. Wilke’s principal research interest is in clinical trials seeking novel methods of treating patients with breast cancer. Dr. Wilke is a member of the Commission on Cancer. She is also a collaborator on multiple grants and trials evaluating novel treatments for breast cancer.

Recent Publications

  • Does persistent use of radiation in women > 70 years of age with early-stage breast cancer reflect tailored patient-centered care?
    Taylor LJ, Steiman JS, Anderson B, Schumacher JR, Wilke LG, Greenberg CC, Neuman HB
    Breast Cancer Res. Treat. 2020 Apr; 180(3): 801-807
    [PubMed ID: 32125557]

  • Evaluation of Long-Term Satisfaction with Breast Surgery in Patients Treated for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
    Livingston-Rosanoff D, Trentham-Dietz A, Hampton JM, Newcomb PA, Wilke LG
    Ann. Surg. Oncol. 2020 Feb 24;
    [PubMed ID: 32095924]

  • Outcomes for Patients with Residual Stage II/III Breast Cancer Following Neoadjuvant Chemotherapy (AFT-01).
    Stankowski-Drengler TJ, Schumacher JR, Hanlon B, Livingston-Rosanoff D, Van de Walle K, Greenberg CC, Wilke LG, Neuman HB
    Ann. Surg. Oncol. 2020 Mar; 27(3): 637-644
    [PubMed ID: 31900808]

  • Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women.
    Vande Walle K, Yang DY, Stankowski-Drengler TJ, Livingston-Rosanoff D, Fernandes-Taylor S, Schumacher JR, Wilke LG, Greenberg CC, Neuman HB
    Ann. Surg. Oncol. 2019 Dec; 26(13): 4310-4316
    [PubMed ID: 31538286]

  • Time to initiation of neo-adjuvant chemotherapy for breast cancer treatment does not influence patient survival: A study of US breast cancer patients.
    Livingston-Rosanoff D, Hanlon B, Marka N, Vande Walle K, Stankowski-Drengler T, Schumacher J, Greenberg CC, Neuman H, Wilke LG
    Breast J 2019 Sep 12;
    [PubMed ID: 31513322]

All Publications on PubMed